FDA approves Travere's Filspari as first drug for the kidney disease called FSGS
Benjamin Ebert became CEO of Dana-Farber Cancer Institute at an inflection point in late 2024, helming the organization in the midst of building a massive $1.6 billion cancer...
Hanan Balkhy has a lot on her plate these days. Balkhy is the director of the World Health Organization’s Eastern Mediterranean region, an entity that includes...
Seeking to cap the cost of medicines, the Maryland Prescription Drug Affordability Board set an upper payment limit for a widely prescribed diabetes treatment, marking only...
Post Content
Nature Biotechnology, Published online: 14 April 2026; doi:10.1038/s41587-026-03095-3 FAMSA2 accurately aligns millions of protein sequences at high speed.
In a bid toward greater transparency, the Food and Drug Administration sent reminder letters to more than 2,200 companies and researchers that they are required to...
A federal judge has tossed one of the four pending civil lawsuits against HaloMD, a company that represents providers in No Surprises Act arbitration cases. The...
Click Therapeutics cuts 27% of workforce after $50M raise
Immune system aging, known as immunosenescence, is associated with changes in immune cell composition and function that increase susceptibility to disease. The results of a study...